CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5 | -99.9% | 4 | -99.9% | 0.00% | – |
| Q1 2024 | $8,268 | +165260.0% | 5,404 | +135000.0% | 0.00% | – |
| Q4 2023 | $5 | +66.7% | 4 | 0.0% | 0.00% | – |
| Q3 2023 | $3 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q3 2021 | $155,000 | +244.4% | 25,815 | +41.8% | 0.00% | +100.0% |
| Q1 2021 | $45,000 | -82.1% | 18,206 | -80.2% | 0.00% | -75.0% |
| Q4 2020 | $252,000 | +50.0% | 91,814 | -16.0% | 0.00% | +100.0% |
| Q3 2020 | $168,000 | +127.0% | 109,313 | +178.4% | 0.00% | +100.0% |
| Q2 2020 | $74,000 | – | 39,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,458,600 | $5,630,000 | 5.96% |
| Carmignac Gestion | 2,485,652 | $5,692,000 | 0.09% |
| XTX Topco Ltd | 50,947 | $117,000 | 0.05% |
| Golden State Equity Partners | 31,327 | $72,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 78,274 | $179,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $725,000 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 27,023 | $62,000 | 0.01% |
| Curi Wealth Management, LLC | 25,000 | $57,000 | 0.01% |
| Northeast Financial Consultants Inc | 53,000 | $121,000 | 0.01% |
| Assenagon Asset Management S.A. | 913,789 | $2,093,000 | 0.01% |